Brian C Bowen

Dr Mellon decided to become a doctor after watching the struggles of several family members with cancer and other serious medical illnesses. He approaches every patient with the promises he made to his sick parents: explain everything clearly to non-doctors, take as much time as needed to answer all questions, and treat patients as if they were family. Shortly after arriving at the University of Miami in 2016, Dr Mellon took the lead of radiation oncology for brain and spine tumors. He is proud to work every day with a close team of UM and Jackson neurosurgeons, neuro-oncologists, and others to provide the most advanced and compassionate care possible. Dr Mellon also works hard to balance research with clinical care.

Dr Abramowitz is an Associate Professor in the Department of Radiation Oncology at the Sylvester Comprehensive Cancer Center, University of Miami Miller School of Medicine. He obtained a BA in biochemistry from Colgate University in 1998 where he was also a member of the men's rowing team and spent 6 months at NIH researching 3D protein structures using NMR (MRI). He worked as a Research Assistant at the University of Massachusetts School of Medicine in the Department of molecular Genetics and Microbiology while serving as the novice rowing coach for College of the Holy. He graduated with honors (AOA) from Temple University School in2003.

Dr Brandon Mahal is a physician-scientist at the University of Miami Miller School of Medicine (MSOM)-Sylvester Comprehensive Cancer Center (SCCC).Dr Mahal treats prostate and genitourinary cancers.Dr Mahal obtained his Doctor of Medicine (MD) with Honors at Harvard Medical School, completed an internal medicine internship at Harvard Medical School's Brigham and Women's Hospital, and completed residency in radiation oncology at the Harvard Radiation Oncology Program.Dr Mahal is an internationally recognized expert in prostate cancer and health equity, with over 200 co-authored manuscripts including several publications in top medical journals such as NEJM, JAMA, and JAMA Oncology.